about
Chikungunya virus infectionThe challenge of chronic chikungunyaDelayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine.Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012.Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: A systematic review.Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient.Epidemiological profile of cutaneous larva migrans in travelers returning to France between 2003 and 2015.Inflammation of the external ear in acute chikungunya infection: Experience from the outbreak in Johor Bahru, Malaysia, 2008.Extended spectrum of antibiotic susceptibility for tuberculosis, djibouti.Human immunodeficiency virus (HIV)-associated epidermodysplasia verruciformis eradicated after interferon-α and ribavirin treatment.Delayed Onset of Plasmodium falciparum Malaria after Doxycycline Prophylaxis in a Soldier Returning from the Central African Republic.Post-Chikungunya rheumatoid arthritis, Saint Martin.Vector control versus case isolation for chikungunya.Treatment for Uncomplicated Plasmodium falciparum Malaria in French Soldiers Deployed in Sub-Saharan Africa: Gaps Between Policy and Field Practice.Chikungunya, the emerging migratory rheumatism.Clinical spectrum of post-chikungunya rheumatic musculoskeletal disorders and use of disease-modifying antirheumatic drugs to treat the chronic inflammatory entities: 6-year experience from Reunion Island.Occurrence of Chronic Stage Chikungunya in the General Population of Martinique during the First 2014 Epidemic: A Prospective Epidemiological StudyNeurotropism of arboviruses seen by a physiatric view, Martiniquaises experiences through epidemics of Dengue, Chikungunya and ZikaShould travellers be offered vaccination against the dengue virus?Increased risk of chikungunya infection in travellers to Thailand during ongoing outbreak in tourist areas: cases imported to Europe and the Middle East, early 2019Tracking Rift Valley fever: From Mali to Europe and other countries, 2016Letter to the editor: False-positive results with rapid diagnostic tests (RDT) for dengue.Authors' response: Chikungunya infection in travellers to Thailand: additional United Kingdom cases identified by specialist laboratorySevere atazanavir-associated hyperbilirubinemia revealing Canton G6PD deficiency in an Asian HIV-infected patient[Pruritus relieved by cardiac stimulation]A 78-year-old woman with an acute eosinophilic gastroenteritisThe challenging management of Rift Valley Fever in humans: literature review of the clinical disease and algorithm proposalRickettsia sibirica mongolitimonae human infection: A diagnostic challengeMeasles, the need for a paradigm shiftClinical Features of Mycobacterium canettii Infection: A Retrospective Study of 20 Cases Among French Soldiers and RelativesChloroquine as prophylactic agent against COVID-19?Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemicTravel-associated chikungunya acquired in Myanmar in 2019
P50
Q24497757-C4832574-BA4E-4FA9-AC98-58C8F781E3B2Q28804236-BF3AC6E1-7A5D-4927-ADE9-B82B6B71DB5EQ30397706-811C1578-0A8B-4ADE-BE86-85CCE02CE7B2Q35168183-597668D3-93E6-402C-A51D-202C0FE6E1A3Q36400444-0FA6C86C-8447-415B-AEB0-40C97E54783AQ37267688-A4391F37-6931-4D82-BB4F-09C5AE631D47Q38721070-6019F069-9526-4797-BA57-A29CEDC7E983Q39102456-BC33BB5E-D20B-4EC4-950F-38F56FEB908EQ40133546-AB385A39-929A-4A2F-8CE2-B13B489C6B84Q42228429-7E644B9C-74F0-4CBA-827C-E1AB1E6DD7D7Q42934098-ADF23C0A-6124-4FF1-BF54-16AA041598D4Q43167196-68D5F717-C1A1-489C-A12E-7DF12816E836Q44849691-1AFF5C9C-DFEA-4A8F-AB85-37E652C94A36Q50051330-A46119A8-46B3-47D7-AAD2-FBFF559592AFQ51024983-8D6EA123-3FE0-43BB-AFFB-9F9A764845AAQ55619040-2D0E2686-C022-4C31-8918-4A6EF857488FQ56448842-F6E65E6A-51E2-4A6C-8A37-CBA479DCFD93Q56448935-3BADD418-BABA-4805-834F-9F3848F8386EQ59351609-AA164A08-21EC-4A64-899A-5599CCAE2D88Q63246365-707C8502-CC8A-4D6A-8BDB-BBDF01036A85Q63246440-4E468AC0-FF29-47DD-A30D-18F9175F720DQ64882294-1FB5D36A-55F8-4F93-8616-B6A7B710C315Q66679634-C34641AA-CAFA-47B9-91A7-BC4E324A52E7Q83011375-89834BC2-9F8D-419F-AAFD-A485A8A54FFDQ83939413-D5AC8F07-66D6-49FA-BF28-80E41A79FA79Q84703948-815F1771-99A6-465B-8CF4-26A030304F5AQ84957526-BED862EC-4686-4F69-BD91-7B6A6F02EBE2Q90251389-70601650-E4F7-42C5-A5F7-1CFA751607A0Q90785794-922D5B04-2CD9-4491-B93D-CDFBDAD425CCQ91501203-07D8307B-9057-4A63-8613-135780A60DDFQ91958492-0232F30D-35AD-41D3-931B-6B37766AF07FQ92026021-AD298CC8-9B51-4792-8BC7-F7B45F801BB0Q92640434-1F270F88-D23D-443A-A858-5BAAD3D8A4B6
P50
description
researcher (ORCID 0000-0003-3760-3537)
@en
wetenschapper
@nl
name
Emilie Javelle
@en
Emilie Javelle
@nl
type
label
Emilie Javelle
@en
Emilie Javelle
@nl
prefLabel
Emilie Javelle
@en
Emilie Javelle
@nl
P31
P496
0000-0003-3760-3537